Artificial Pancreas Device System (APDS) Market Size, Share & Trends Analysis Report By Device Type (Threshold suspended device system, CTT System) And Segment Forecasts, 2013 - 2024

  • ID: 4538776
  • Report
  • 112 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • Beta Bionics
  • Bigfoot Biomedical
  • Johnson & Johnson
  • Medtronic
  • Pancreum, Inc.
  • MORE
The global artificial pancreas device system market is anticipated to reach USD 390.4 million by 2024. Increasing prevalence of diabetes, intensive R&D efforts by industry players, and rising demand for automated systems for glycemic control are the key factors that are driving the market growth.

Regulatory bodies such as FDA are continuously approving new and innovative products which is increasing the reach of the companies in various market. For instance, in December 2016, OneTouch Vibe plus Insulin Pump by Animas received FDA approval and Health Canada License for the sale of the product. In January 2016, Animas received FDA approval for Animas Vibe Insulin Pump, the device to manage of diabetes in children and adolescents.

Similarly, in June 2016, Tandem Diabetes Care cleared its FDA approval for remote software update tool for insulin pump. Also, in September 2016, the company received FDA approval for their product t:slim G4 Insulin Pump giving the diabetes community a powerful new tool to help simplify therapy managementSuch factors are contributing to the growth of the market.

Additionally, the prevalence of diabetes is increasing in low and middle-income counties owing to the sedentary lifestyle, genetic modification, obesity, lack of physical activity, and unhealthy diet. According to the data published by the International Diabetes Federation(IDF), in 2015 there were about 415 million people suffering from diabetes globally. Also, Based on the information provided by the American Diabetes Association, in 2012, about 29.1 million Americans suffered from diabetes out of which 90% were of type2 and 1.25 million suffered from type 1 diabetes. Furthermore, the increasing dependency of type 2 diabetes on insulin is expected to create opportunities for the artificial pancreas devices market.

Further Key Findings From the Study Suggest:
  • Control to Target (CTT) systems is anticipated to witness fastest growth during the forecast period as they are fully automated and require no intervention on the patient’s part for the administration of insulin or for the monitoring of glucose levels.
  • Asia Pacific artificial pancreas device system market is expected to grow with the highest CAGR over the forecast period owing to the lifestyle, genetic modification, urbanization and aging population.
  • Major players of the market include, Medtronic Plc, Bigfoot Biomedical, Johnson & Johnson, Tandem Diabetes Care, Inc., Pancreum, Inc., TypeZero Technologies, LLC, and Beta Bionics.


PLEASE NOTE:
This report will be completed after order and will take approximately 1-2 business days after the confirmation of payment.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Beta Bionics
  • Bigfoot Biomedical
  • Johnson & Johnson
  • Medtronic
  • Pancreum, Inc.
  • MORE
Chapter 1 Research Methodology
1.1 Research Methodology
1.2 Research Scope & Assumptions
1.3 List of Data Sources

Chapter 2 Executive Summary

Chapter 3 Market Summary

Chapter 4 Market Variables, Trends & Scope
4.1 Market Segmentation & Scope
4.2 Market Driver Analysis
4.3 Market Restraint Analysis
4.4 Penetration & Growth Prospect Mapping
4.5 SWOT Analysis, By Factor
4.5.1 Political
4.5.2 Economic
4.5.3 Technology

Chapter 5 Market Categorization 1: Device Type Estimates & Trend Analysis
5.1 Device Type Movement Analysis & Market Share, 2015 & 2024
5.2 Market Size & Forecasts and Trend Analyses, 2013 to 2024 for the following device types:
5.2.1 Threshold suspended device system
5.2.2 CTR system
5.2.3 CTT system

Chapter 6 Market Categorization 2: Regional Estimates & Trend Analysis
6.1 Regional Movement Analysis & Market Share, 2015 & 2024
6.2 Market Size & Forecasts and Trend Analyses, 2013 to 2024 for the following regions:
6.2.1 North America
6.2.1.1 U.S.
6.2.1.2 Canada
6.2.2 Europe
6.2.2.1 UK
6.2.2.2 Germany
6.2.3 Asia Pacific
6.2.3.1 Japan
6.2.3.2 China
6.2.4 Latin America
6.2.4.1 Brazil
6.2.4.2 Mexico
6.2.5 MEA
6.2.5.1 South Africa

Chapter 7 Competitive Landscape
7.1 Strategy Framework
7.2 Company Profiles
7.2.1 Medtronic
7.2.1.1 Company Overview
7.2.1.2 Financial Performance
7.2.1.3 Product Benchmarking
7.2.1.4 Strategic Initiatives
7.2.2 Bigfoot Biomedical
7.2.2.1 Company Overview
7.2.2.2 Financial Performance
7.2.2.3 Product Benchmarking
7.2.2.4 Strategic Initiatives
7.2.3 Johnson & Johnson
7.2.3.1 Company Overview
7.2.3.2 Financial Performance
7.2.3.3 Product Benchmarking
7.2.3.4 Strategic Initiatives
7.2.4 Tandem Diabetes Care, Inc.
7.2.4.1 Company Overview
7.2.4.2 Financial Performance
7.2.4.3 Product Benchmarking
7.2.4.4 Strategic Initiatives
7.2.5 Pancreum, Inc.
7.2.5.1 Company Overview
7.2.5.2 Financial Performance
7.2.5.3 Product Benchmarking
7.2.5.4 Strategic Initiatives
7.2.6 TypeZero Technologies, LLC
7.2.6.1 Company Overview
7.2.6.2 Financial Performance
7.2.6.3 Product Benchmarking
7.2.6.4 Strategic Initiatives
7.2.7 Beta Bionics
7.2.7.1 Company Overview
7.2.7.2 Financial Performance
7.2.7.3 Product Benchmarking
7.2.7.4 Strategic Initiatives

List of Tables

Table 1 North America artificial pancreasdevice systemmarket, by region, 2013 - 2024 (USD Million)
Table 2 North America artificial pancreas device system market, by Device Type, 2013 - 2024 (USD Million)
Table 3 U.S. artificial pancreasdevice system market, by device type, 2013 - 2024 (USD Million)
Table 4 Canada artificial pancreasdevice system market, by device type, 2013 - 2024 (USD Million)
Table 5 Europe artificial pancreasdevice system market, byregion, 2013 - 2024 (USD Million)
Table 6 Europe artificial pancreasdevice system market, by device type, 2013 - 2024 (USD Million)
Table 7 UK artificial pancreasdevice system market, by device type, 2013 - 2024 (USD Million)
Table 8 Germany artificial pancreasdevice system market, by device type, 2013 - 2024 (USD Million)
Table 9 Asia Pacific artificial pancreasdevice system market, by region, 2013 - 2024 (USD Million)
Table 10 Asia Pacific artificial pancreasdevice system market, by device type, 2013 - 2024 (USD Million)
Table 11 Japan artificial pancreasdevice system market, by device type, 2013 - 2024 (USD Million)
Table 12 China artificial pancreasdevice system market, by device type, 2013 - 2024 (USD Million)
Table 13 Latin America artificial pancreasdevice system market, by region 2013 - 2024 (USD Million)
Table 14 Latin America artificial pancreasdevice system market, by device type, 2013 - 2024 (USD Million)
Table 15 Brazil artificial pancreasdevice system market, by device type, 2013 - 2024 (USD Million)
Table 16 Mexico artificial pancreasdevice system market, bydevice type, 2013 - 2024 (USD Million)
Table 17 MEA artificial pancreasdevice system market, by region, 2013 - 2024 (USD Million)
Table 18 MEA artificial pancreasdevice system market, by device type, 2013 - 2024 (USD Million)
Table 19 South Africa artificial pancreasdevice system market, by device type, 2013 - 2024 (USD Million)

List of Figures

FIG. 1 Market summary
FIG. 2 Market trends & outlook
FIG. 3 Market segmentation & scope
FIG. 4 Market driver relevance analysis (Current & future impact)
FIG. 5 Market restraint relevance analysis (Current & future impact)
FIG. 6 Penetration & growth prospect mapping
FIG. 7 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 8 Porter’s Five Forces Analysis
FIG. 9 Artificial pancreas market device type outlook:Key takeaways
FIG. 10 Artificial pancreas: Device type movement analysis
FIG. 11 Threshold Suspended Device System Market, 2013 - 2024 (USD Million)
FIG. 12 CTR System Market, 2013 - 2024 (USD Million)
FIG. 13 CTT System Market, 2013 - 2024 (USD Million)
FIG. 14 Regional market place: Key takeaways
FIG. 15 Strategy framework
FIG. 16 Participant categorization
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Medtronic
  • Bigfoot Biomedical
  • Johnson & Johnson
  • Tandem Diabetes Care, Inc.
  • Pancreum, Inc.
  • TypeZero Technologies, LLC
  • Beta Bionics
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll